-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
311 ，。，，，202080%。，“”。TOP20，11，、、5“”；、、。TOP20，、、。
20！、、……11“”
，20，2020，。，，80%。
2020E（：）
：
，“”，。2，，、、51。
2020ETOP20
：
：*
TOP20，11，、、、9，，、、5“”；、、。，，11；，8。
2020ETOP20
：
TOP20，、、，、、TOP20。
，
（：）
：
。，1，。，，、、，，、、、13，。，、，、、，。
The market share of the three major products of Zhuzhou Qianjin Pharmaceutical in recent years in physical pharmacies in key cities of gynecological Chinese patent medicines
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Gynecological Qianjin Tablets and Gynecological Qianjin Capsules are exclusive products of Zhuzhou Qianjin Pharmaceutical.
M within the network data, expected in 2020 in key cities entity pharmacies to gynecological drugs brand TOP20, Zhuzhou Qianjin Pharmaceutical Qianjinpian, gynecology daughter capsule, Yimu particles are in them.
According to the data, Qianjin Pharmaceutical has made product layout for women's "fifth period" menstruation, pregnancy, childbirth, feeding, and other gynecological diseases that may occur at different stages, and the leading products Gynecological Qianjin Tablets and Gynecological Qianjin Capsules are used for the treatment of pelvic inflammatory diseases.
, It is the exclusive possession of national Chinese medicine protected varieties, national essential drugs list, national medical insurance list varieties, national secret technology varieties, national invention patent varieties, and "Chinese Pharmacopoeia" varieties.
It is worth mentioning that in addition to the exclusive varieties of Chunju gel and gynecological broken red drink capsules in the field of proprietary Chinese medicines, the company has also developed a number of products with high growth potential in the field of traditional Chinese medicine derivatives and women’s health.
.
M within the network data, expected in 2020 in key cities entity pharmacies to gynecological drugs brand TOP20, Zhuzhou Qianjin Pharmaceutical Qianjinpian, gynecology daughter capsule, Yimu particles are in them.
According to the data, Qianjin Pharmaceutical has made product layout for women's "fifth period" menstruation, pregnancy, childbirth, feeding, and other gynecological diseases that may occur at different stages, and the leading products Gynecological Qianjin Tablets and Gynecological Qianjin Capsules are used for the treatment of pelvic inflammatory diseases.
, It is the exclusive possession of national Chinese medicine protected varieties, national essential drugs list, national medical insurance list varieties, national secret technology varieties, national invention patent varieties, and "Chinese Pharmacopoeia" varieties.
It is worth mentioning that in addition to the exclusive varieties of Chunju gel and gynecological broken red drink capsules in the field of proprietary Chinese medicines, the company has also developed a number of products with high growth potential in the field of traditional Chinese medicine derivatives and women’s health.
.
Xiaoyao Pill "Hundred Schools of Thought", Zhongjing Wanxi Pharmaceutical stands out! The growth rate of Jiawei Xiaoyao Pills is nearly 10%
Sales of Xiaoyao Pills in physical pharmacies in key cities in recent years (unit: 100 million yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
According to data from Meinnet.
com, the sales of Xiaoyao pills in physical pharmacies in key cities have increased steadily in recent years, and it is expected that in 2020, it will rise by one position in the TOP20 gynecological Chinese patent medicine products, and will be promoted to third.
Among them, Zhongjing Wanxi Pharmaceutical has the largest market share, close to 60%; followed by Jiuzhitang with more than 15%.
There are many manufacturers of Xiaoyao pills and fierce competition, including more than 150 such as Zhongjing Wanxi Pharmaceutical, Jiuzhitang, Lanzhou Foci Pharmaceutical, and Taiji Group Chongqing Second Chinese Medicine Factory.
com, the sales of Xiaoyao pills in physical pharmacies in key cities have increased steadily in recent years, and it is expected that in 2020, it will rise by one position in the TOP20 gynecological Chinese patent medicine products, and will be promoted to third.
Among them, Zhongjing Wanxi Pharmaceutical has the largest market share, close to 60%; followed by Jiuzhitang with more than 15%.
There are many manufacturers of Xiaoyao pills and fierce competition, including more than 150 such as Zhongjing Wanxi Pharmaceutical, Jiuzhitang, Lanzhou Foci Pharmaceutical, and Taiji Group Chongqing Second Chinese Medicine Factory.
Sales of Jiawei Xiaoyao Pills in physical pharmacies in key cities in recent years (unit: ten thousand yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
According to data from Meinenet, the sales of Jiawei Xiaoyao Pills in Chinese urban retail pharmacies have grown steadily in recent years, and are expected to increase by nearly 10% year-on-year in 2020, jumping from 10th to 8th in 2019.
Among them, Beijing Tongrentang Technology Pharmaceutical has the largest market share, with more than 50%; followed by Zhuzhou Qianjin Pharmaceutical with more than 30%.
The manufacturers of Jiawei Xiaoyao Pills include more than 30 companies including Beijing Tongrentang Technology Pharmaceutical, Zhuzhou Qianjin Pharmaceutical, Kunming Traditional Chinese Medicine, Zhongxin Pharmaceutical Lerentang Pharmaceutical, and Tianjin Tasly (Liaoning) Pharmaceutical.
Among them, Beijing Tongrentang Technology Pharmaceutical has the largest market share, with more than 50%; followed by Zhuzhou Qianjin Pharmaceutical with more than 30%.
The manufacturers of Jiawei Xiaoyao Pills include more than 30 companies including Beijing Tongrentang Technology Pharmaceutical, Zhuzhou Qianjin Pharmaceutical, Kunming Traditional Chinese Medicine, Zhongxin Pharmaceutical Lerentang Pharmaceutical, and Tianjin Tasly (Liaoning) Pharmaceutical.
Data source: Mi Neiwang database, company annual report, etc.
Medical Network News, March 11 With the development of society and the improvement of living standards, women also attach great importance to health care.
According to data from Minaiwang, in recent years, in the gynecological Chinese patent medicine market of physical pharmacies in key cities, gynecological menstrual regulation drugs and gynecological inflammation drugs are still the two main forces, and the total market share is expected to exceed 80% in 2020.
From the perspective of urban structure, the sales of the four major cities of "Beijing, Shanghai, Guangzhou and Shenzhen" are among the best.
Among the TOP20 products, 11 are exclusive products.
Five of them, including Jie'eryin Lotion, Baofukang Suppository, and Gynecological Qianjin Tablets, are "preempting" the top ten; Xiaoyao Pills, Jiawei Xiaoyao Pills, and Tongren Wuji Baifeng buck the trend.
Among the TOP20 brands, Dingkundan from Shanxi Guangyuyuan Sinopharm, Jieryin Lotion from Sichuan Enwei Pharmaceutical, and Baofukang Suppository from Hainan Bikai Pharmaceutical rank in the top three.
According to data from Minaiwang, in recent years, in the gynecological Chinese patent medicine market of physical pharmacies in key cities, gynecological menstrual regulation drugs and gynecological inflammation drugs are still the two main forces, and the total market share is expected to exceed 80% in 2020.
From the perspective of urban structure, the sales of the four major cities of "Beijing, Shanghai, Guangzhou and Shenzhen" are among the best.
Among the TOP20 products, 11 are exclusive products.
Five of them, including Jie'eryin Lotion, Baofukang Suppository, and Gynecological Qianjin Tablets, are "preempting" the top ten; Xiaoyao Pills, Jiawei Xiaoyao Pills, and Tongren Wuji Baifeng buck the trend.
Among the TOP20 brands, Dingkundan from Shanxi Guangyuyuan Sinopharm, Jieryin Lotion from Sichuan Enwei Pharmaceutical, and Baofukang Suppository from Hainan Bikai Pharmaceutical rank in the top three.
20 gynaecological Chinese patent medicine pharmacies are selling well! Enwei, daughter, step length.
.
.
11 exclusive products "Baping"
.
.
11 exclusive products "Baping"
According to data from Mi Nei.
com, in recent years, the sales of gynecological Chinese patent medicines in physical pharmacies in key cities have maintained about 2 billion yuan.
In 2020, affected by the epidemic, it is expected to decline year-on-year.
In terms of sub-categories, gynecological inflammation drugs and gynecological menstruation drugs are still the two main forces, with a total market share of more than 80%.
com, in recent years, the sales of gynecological Chinese patent medicines in physical pharmacies in key cities have maintained about 2 billion yuan.
In 2020, affected by the epidemic, it is expected to decline year-on-year.
In terms of sub-categories, gynecological inflammation drugs and gynecological menstruation drugs are still the two main forces, with a total market share of more than 80%.
2020E key city entity pharmacy gynecological Chinese patent medicine city layout (unit: ten thousand yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
From the perspective of the urban structure, the sales of the four major cities of "Beijing, Shanghai, Guangzhou and Shenzhen" rank among the top, and have consistently ranked among the top four for many years.
Shenzhen is the only city with sales of more than 200 million yuan.
In addition, five cities including Shanghai, Guangzhou and Beijing have sales of more than 100 million yuan.
Shenzhen is the only city with sales of more than 200 million yuan.
In addition, five cities including Shanghai, Guangzhou and Beijing have sales of more than 100 million yuan.
2020E Key City Entity Pharmacy Gynecological Chinese Patent Medicine Products TOP20
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Note: * is exclusive
Among the TOP20 products, there are 11 exclusive products, involving 9 companies including Sichuan Enwei Pharmaceutical, Zhuzhou Qianjin Pharmaceutical, Shandong Buchang Shenzhou Pharmaceutical, Jiangsu Kangyuan Pharmaceutical, etc.
Among them, Jieeryin Lotion, Baofukang Suppository, Five exclusive products such as Gynecology Qianjin Tablets "occupies" the top ten; Xiaoyao Pills, Jiawei Xiaoyao Pills, and Tongren Wuji Baifeng bucked the trend.
In terms of sub-categories, gynecological inflammation drugs are the most used, with 11; followed by gynecological menstruation regulating drugs, with 8.
Among them, Jieeryin Lotion, Baofukang Suppository, Five exclusive products such as Gynecology Qianjin Tablets "occupies" the top ten; Xiaoyao Pills, Jiawei Xiaoyao Pills, and Tongren Wuji Baifeng bucked the trend.
In terms of sub-categories, gynecological inflammation drugs are the most used, with 11; followed by gynecological menstruation regulating drugs, with 8.
2020E TOP20 Gynecological Chinese Patent Medicine Brands in Entity Pharmacies in Key Cities
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Among the TOP20 brands, Dingkundan from Shanxi Guangyuyuan Sinopharm, Jieryin Lotion from Sichuan Enwei Pharmaceutical, and Baofukang Suppository from Hainan Bikai Pharmaceutical are among the top three, and Zhuzhou Qianjin Pharmaceutical's Gynecological Qianjin Tablets and Gynecology Qianjin Capsules and Yimu Granules rank among the TOP20 brands.
Enwei holds exclusive products and ranks among the top three, and the three Qianjin brands are eye-catching
Sales of Jieeryin Lotion in Entity Pharmacies in Key Cities in Recent Years (Unit: 100 million yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Jieryin lotion is the exclusive product of Sichuan Enwei Pharmaceutical.
According to data from Meinenet, in recent years, Jieeryin Lotion, an entity drug in key cities, has maintained a sales scale of more than 100 million yuan, ranking first in the market share of Chinese patent medicines for gynecological inflammation for many years.
According to data, Sichuan Enwei Pharmaceutical is a wholly-owned subsidiary of Enwei Pharmaceutical.
Enwei Pharmaceutical focuses on the fields of gynecological products, pediatric medications, and respiratory system medications.
It has been deeply engaged in the field of gynecological products for many years.
There are 13 gynecological drugs such as Eryin Effervescent Tablets, Jieeryin Ointment, and Huayu Shujing Capsules, forming a relatively complete gynecological product system.
In addition to gynecological external use lotion, the company has also continuously developed ointments, suppositories and other dosage forms, as well as antibacterial lotion and other disinfection products, and plans to develop a series of gynecological internal medicine products by means of independent research and development, joint research and development, and purchase of varieties to further enhance the company’s The leading position in the field of domestic gynecological products.
According to data from Meinenet, in recent years, Jieeryin Lotion, an entity drug in key cities, has maintained a sales scale of more than 100 million yuan, ranking first in the market share of Chinese patent medicines for gynecological inflammation for many years.
According to data, Sichuan Enwei Pharmaceutical is a wholly-owned subsidiary of Enwei Pharmaceutical.
Enwei Pharmaceutical focuses on the fields of gynecological products, pediatric medications, and respiratory system medications.
It has been deeply engaged in the field of gynecological products for many years.
There are 13 gynecological drugs such as Eryin Effervescent Tablets, Jieeryin Ointment, and Huayu Shujing Capsules, forming a relatively complete gynecological product system.
In addition to gynecological external use lotion, the company has also continuously developed ointments, suppositories and other dosage forms, as well as antibacterial lotion and other disinfection products, and plans to develop a series of gynecological internal medicine products by means of independent research and development, joint research and development, and purchase of varieties to further enhance the company’s The leading position in the field of domestic gynecological products.
The market share of the three major products of Zhuzhou Qianjin Pharmaceutical in recent years in physical pharmacies in key cities of gynecological Chinese patent medicines
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Gynecological Qianjin Tablets and Gynecological Qianjin Capsules are exclusive products of Zhuzhou Qianjin Pharmaceutical.
M within the network data, expected in 2020 in key cities entity pharmacies to gynecological drugs brand TOP20, Zhuzhou Qianjin Pharmaceutical Qianjinpian, gynecology daughter capsule, Yimu particles are in them.
According to the data, Qianjin Pharmaceutical has made product layout for women's "fifth period" menstruation, pregnancy, childbirth, feeding, and other gynecological diseases that may occur at different stages, and the leading products Gynecological Qianjin Tablets and Gynecological Qianjin Capsules are used for the treatment of pelvic inflammatory diseases.
, It is the exclusive possession of national Chinese medicine protected varieties, national essential drugs list, national medical insurance list varieties, national secret technology varieties, national invention patent varieties, and "Chinese Pharmacopoeia" varieties.
It is worth mentioning that in addition to the exclusive varieties of Chunju gel and gynecological broken red drink capsules in the field of proprietary Chinese medicines, the company has also developed a number of products with high growth potential in the field of traditional Chinese medicine derivatives and women’s health.
.
M within the network data, expected in 2020 in key cities entity pharmacies to gynecological drugs brand TOP20, Zhuzhou Qianjin Pharmaceutical Qianjinpian, gynecology daughter capsule, Yimu particles are in them.
According to the data, Qianjin Pharmaceutical has made product layout for women's "fifth period" menstruation, pregnancy, childbirth, feeding, and other gynecological diseases that may occur at different stages, and the leading products Gynecological Qianjin Tablets and Gynecological Qianjin Capsules are used for the treatment of pelvic inflammatory diseases.
, It is the exclusive possession of national Chinese medicine protected varieties, national essential drugs list, national medical insurance list varieties, national secret technology varieties, national invention patent varieties, and "Chinese Pharmacopoeia" varieties.
It is worth mentioning that in addition to the exclusive varieties of Chunju gel and gynecological broken red drink capsules in the field of proprietary Chinese medicines, the company has also developed a number of products with high growth potential in the field of traditional Chinese medicine derivatives and women’s health.
.
Xiaoyao Pill "Hundred Schools of Thought", Zhongjing Wanxi Pharmaceutical stands out! The growth rate of Jiawei Xiaoyao Pills is nearly 10%
Sales of Xiaoyao Pills in physical pharmacies in key cities in recent years (unit: 100 million yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
According to data from Meinnet.
com, the sales of Xiaoyao pills in physical pharmacies in key cities have increased steadily in recent years, and it is expected that in 2020, it will rise by one position in the TOP20 gynecological Chinese patent medicine products, and will be promoted to third.
Among them, Zhongjing Wanxi Pharmaceutical has the largest market share, close to 60%; followed by Jiuzhitang with more than 15%.
There are many manufacturers of Xiaoyao pills and fierce competition, including more than 150 such as Zhongjing Wanxi Pharmaceutical, Jiuzhitang, Lanzhou Foci Pharmaceutical, and Taiji Group Chongqing Second Chinese Medicine Factory.
com, the sales of Xiaoyao pills in physical pharmacies in key cities have increased steadily in recent years, and it is expected that in 2020, it will rise by one position in the TOP20 gynecological Chinese patent medicine products, and will be promoted to third.
Among them, Zhongjing Wanxi Pharmaceutical has the largest market share, close to 60%; followed by Jiuzhitang with more than 15%.
There are many manufacturers of Xiaoyao pills and fierce competition, including more than 150 such as Zhongjing Wanxi Pharmaceutical, Jiuzhitang, Lanzhou Foci Pharmaceutical, and Taiji Group Chongqing Second Chinese Medicine Factory.
Sales of Jiawei Xiaoyao Pills in physical pharmacies in key cities in recent years (unit: ten thousand yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
According to data from Meinenet, the sales of Jiawei Xiaoyao Pills in Chinese urban retail pharmacies have grown steadily in recent years, and are expected to increase by nearly 10% year-on-year in 2020, jumping from 10th to 8th in 2019.
Among them, Beijing Tongrentang Technology Pharmaceutical has the largest market share, with more than 50%; followed by Zhuzhou Qianjin Pharmaceutical with more than 30%.
The manufacturers of Jiawei Xiaoyao Pills include more than 30 companies including Beijing Tongrentang Technology Pharmaceutical, Zhuzhou Qianjin Pharmaceutical, Kunming Traditional Chinese Medicine, Zhongxin Pharmaceutical Lerentang Pharmaceutical, and Tianjin Tasly (Liaoning) Pharmaceutical.
Among them, Beijing Tongrentang Technology Pharmaceutical has the largest market share, with more than 50%; followed by Zhuzhou Qianjin Pharmaceutical with more than 30%.
The manufacturers of Jiawei Xiaoyao Pills include more than 30 companies including Beijing Tongrentang Technology Pharmaceutical, Zhuzhou Qianjin Pharmaceutical, Kunming Traditional Chinese Medicine, Zhongxin Pharmaceutical Lerentang Pharmaceutical, and Tianjin Tasly (Liaoning) Pharmaceutical.
Data source: Mi Neiwang database, company annual report, etc.
Medical Network News, March 11 With the development of society and the improvement of living standards, women also attach great importance to health care.
According to data from Minaiwang, in recent years, in the gynecological Chinese patent medicine market of physical pharmacies in key cities, gynecological menstrual regulation drugs and gynecological inflammation drugs are still the two main forces, and the total market share is expected to exceed 80% in 2020.
From the perspective of urban structure, the sales of the four major cities of "Beijing, Shanghai, Guangzhou and Shenzhen" are among the best.
Among the TOP20 products, 11 are exclusive products.
Five of them, including Jie'eryin Lotion, Baofukang Suppository, and Gynecological Qianjin Tablets, are "preempting" the top ten; Xiaoyao Pills, Jiawei Xiaoyao Pills, and Tongren Wuji Baifeng buck the trend.
Among the TOP20 brands, Dingkundan from Shanxi Guangyuyuan Sinopharm, Jieryin Lotion from Sichuan Enwei Pharmaceutical, and Baofukang Suppository from Hainan Bikai Pharmaceutical rank in the top three.
According to data from Minaiwang, in recent years, in the gynecological Chinese patent medicine market of physical pharmacies in key cities, gynecological menstrual regulation drugs and gynecological inflammation drugs are still the two main forces, and the total market share is expected to exceed 80% in 2020.
From the perspective of urban structure, the sales of the four major cities of "Beijing, Shanghai, Guangzhou and Shenzhen" are among the best.
Among the TOP20 products, 11 are exclusive products.
Five of them, including Jie'eryin Lotion, Baofukang Suppository, and Gynecological Qianjin Tablets, are "preempting" the top ten; Xiaoyao Pills, Jiawei Xiaoyao Pills, and Tongren Wuji Baifeng buck the trend.
Among the TOP20 brands, Dingkundan from Shanxi Guangyuyuan Sinopharm, Jieryin Lotion from Sichuan Enwei Pharmaceutical, and Baofukang Suppository from Hainan Bikai Pharmaceutical rank in the top three.
20 gynaecological Chinese patent medicine pharmacies are selling well! Enwei, daughter, step length.
.
.
11 exclusive products "Baping"
20 gynaecological Chinese patent medicine pharmacies are selling well! Enwei, daughter, step length. .
.
11 exclusive products "Baping"
.
.
11 exclusive products "Baping"
According to data from Mi Nei.
com, in recent years, the sales of gynecological Chinese patent medicines in physical pharmacies in key cities have maintained about 2 billion yuan.
In 2020, affected by the epidemic, it is expected to decline year-on-year.
In terms of sub-categories, gynecological inflammation drugs and gynecological menstruation drugs are still the two main forces, with a total market share of more than 80%.
com, in recent years, the sales of gynecological Chinese patent medicines in physical pharmacies in key cities have maintained about 2 billion yuan.
In 2020, affected by the epidemic, it is expected to decline year-on-year.
In terms of sub-categories, gynecological inflammation drugs and gynecological menstruation drugs are still the two main forces, with a total market share of more than 80%.
2020E key city entity pharmacy gynecological Chinese patent medicine city layout (unit: ten thousand yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
From the perspective of the urban structure, the sales of the four major cities of "Beijing, Shanghai, Guangzhou and Shenzhen" rank among the top, and have consistently ranked among the top four for many years.
Shenzhen is the only city with sales of more than 200 million yuan.
In addition, five cities including Shanghai, Guangzhou and Beijing have sales of more than 100 million yuan.
Shenzhen is the only city with sales of more than 200 million yuan.
In addition, five cities including Shanghai, Guangzhou and Beijing have sales of more than 100 million yuan.
2020E Key City Entity Pharmacy Gynecological Chinese Patent Medicine Products TOP20
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Note: * is exclusive
Among the TOP20 products, there are 11 exclusive products, involving 9 companies including Sichuan Enwei Pharmaceutical, Zhuzhou Qianjin Pharmaceutical, Shandong Buchang Shenzhou Pharmaceutical, Jiangsu Kangyuan Pharmaceutical, etc.
Among them, Jieeryin Lotion, Baofukang Suppository, Five exclusive products such as Gynecology Qianjin Tablets "occupies" the top ten; Xiaoyao Pills, Jiawei Xiaoyao Pills, and Tongren Wuji Baifeng bucked the trend.
In terms of sub-categories, gynecological inflammation drugs are the most used, with 11; followed by gynecological menstruation regulating drugs, with 8.
Enterprise business enterpriseAmong them, Jieeryin Lotion, Baofukang Suppository, Five exclusive products such as Gynecology Qianjin Tablets "occupies" the top ten; Xiaoyao Pills, Jiawei Xiaoyao Pills, and Tongren Wuji Baifeng bucked the trend.
In terms of sub-categories, gynecological inflammation drugs are the most used, with 11; followed by gynecological menstruation regulating drugs, with 8.
2020E TOP20 Gynecological Chinese Patent Medicine Brands in Entity Pharmacies in Key Cities
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Among the TOP20 brands, Dingkundan from Shanxi Guangyuyuan Sinopharm, Jieryin Lotion from Sichuan Enwei Pharmaceutical, and Baofukang Suppository from Hainan Bikai Pharmaceutical are among the top three, and Zhuzhou Qianjin Pharmaceutical's Gynecological Qianjin Tablets and Gynecology Qianjin Capsules and Yimu Granules rank among the TOP20 brands.
Enwei holds exclusive products and ranks among the top three, and the three Qianjin brands are eye-catching
Enwei holds exclusive products and ranks among the top three, and the three Qianjin brands are eye-catching Sales of Jieeryin Lotion in Entity Pharmacies in Key Cities in Recent Years (Unit: 100 million yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Jieryin lotion is the exclusive product of Sichuan Enwei Pharmaceutical.
According to data from Meinenet, in recent years, Jieeryin Lotion, an entity drug in key cities, has maintained a sales scale of more than 100 million yuan, ranking first in the market share of Chinese patent medicines for gynecological inflammation for many years.
According to data, Sichuan Enwei Pharmaceutical is a wholly-owned subsidiary of Enwei Pharmaceutical.
Enwei Pharmaceutical focuses on the fields of gynecological products, pediatric medications, and respiratory system medications.
It has been deeply engaged in the field of gynecological products for many years.
There are 13 gynecological drugs such as Eryin Effervescent Tablets, Jieeryin Ointment, and Huayu Shujing Capsules, forming a relatively complete gynecological product system.
In addition to gynecological external use lotion, the company has also continuously developed ointments, suppositories and other dosage forms, as well as antibacterial lotion and other disinfection products, and plans to develop a series of gynecological internal medicine products by means of independent research and development, joint research and development, and purchase of varieties to further enhance the company’s The leading position in the field of domestic gynecological products.
Medicine medicine medicine disinfection disinfection sterilizationAccording to data from Meinenet, in recent years, Jieeryin Lotion, an entity drug in key cities, has maintained a sales scale of more than 100 million yuan, ranking first in the market share of Chinese patent medicines for gynecological inflammation for many years.
According to data, Sichuan Enwei Pharmaceutical is a wholly-owned subsidiary of Enwei Pharmaceutical.
Enwei Pharmaceutical focuses on the fields of gynecological products, pediatric medications, and respiratory system medications.
It has been deeply engaged in the field of gynecological products for many years.
There are 13 gynecological drugs such as Eryin Effervescent Tablets, Jieeryin Ointment, and Huayu Shujing Capsules, forming a relatively complete gynecological product system.
In addition to gynecological external use lotion, the company has also continuously developed ointments, suppositories and other dosage forms, as well as antibacterial lotion and other disinfection products, and plans to develop a series of gynecological internal medicine products by means of independent research and development, joint research and development, and purchase of varieties to further enhance the company’s The leading position in the field of domestic gynecological products.
The market share of the three major products of Zhuzhou Qianjin Pharmaceutical in recent years in physical pharmacies in key cities of gynecological Chinese patent medicines
Pharmacy pharmacy pharmacy Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Gynecological Qianjin Tablets and Gynecological Qianjin Capsules are exclusive products of Zhuzhou Qianjin Pharmaceutical.
M within the network data, expected in 2020 in key cities entity pharmacies to gynecological drugs brand TOP20, Zhuzhou Qianjin Pharmaceutical Qianjinpian, gynecology daughter capsule, Yimu particles are in them.
According to the data, Qianjin Pharmaceutical has made product layout for women's "fifth period" menstruation, pregnancy, childbirth, feeding, and other gynecological diseases that may occur at different stages, and the leading products Gynecological Qianjin Tablets and Gynecological Qianjin Capsules are used for the treatment of pelvic inflammatory diseases.
, It is the exclusive possession of national Chinese medicine protected varieties, national essential drugs list, national medical insurance list varieties, national secret technology varieties, national invention patent varieties, and "Chinese Pharmacopoeia" varieties.
It is worth mentioning that in addition to the exclusive varieties of Chunju gel and gynecological broken red drink capsules in the field of proprietary Chinese medicines, the company has also developed a number of products with high growth potential in the field of traditional Chinese medicine derivatives and women’s health.
.
Medicine, medicine, medicineM within the network data, expected in 2020 in key cities entity pharmacies to gynecological drugs brand TOP20, Zhuzhou Qianjin Pharmaceutical Qianjinpian, gynecology daughter capsule, Yimu particles are in them.
According to the data, Qianjin Pharmaceutical has made product layout for women's "fifth period" menstruation, pregnancy, childbirth, feeding, and other gynecological diseases that may occur at different stages, and the leading products Gynecological Qianjin Tablets and Gynecological Qianjin Capsules are used for the treatment of pelvic inflammatory diseases.
, It is the exclusive possession of national Chinese medicine protected varieties, national essential drugs list, national medical insurance list varieties, national secret technology varieties, national invention patent varieties, and "Chinese Pharmacopoeia" varieties.
It is worth mentioning that in addition to the exclusive varieties of Chunju gel and gynecological broken red drink capsules in the field of proprietary Chinese medicines, the company has also developed a number of products with high growth potential in the field of traditional Chinese medicine derivatives and women’s health.
.
Xiaoyao Pill "Hundred Schools of Thought", Zhongjing Wanxi Pharmaceutical stands out! The growth rate of Jiawei Xiaoyao Pills is nearly 10%
Xiaoyao Pill "Hundred Schools of Thought", Zhongjing Wanxi Pharmaceutical stands out! The growth rate of Jiawei Xiaoyao Pills is nearly 10% Sales of Xiaoyao Pills in physical pharmacies in key cities in recent years (unit: 100 million yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
According to data from Meinnet.
com, the sales of Xiaoyao pills in physical pharmacies in key cities have increased steadily in recent years, and it is expected that in 2020, it will rise by one position in the TOP20 gynecological Chinese patent medicine products, and will be promoted to third.
Among them, Zhongjing Wanxi Pharmaceutical has the largest market share, close to 60%; followed by Jiuzhitang with more than 15%.
There are many manufacturers of Xiaoyao pills and fierce competition, including more than 150 such as Zhongjing Wanxi Pharmaceutical, Jiuzhitang, Lanzhou Foci Pharmaceutical, and Taiji Group Chongqing Second Chinese Medicine Factory.
com, the sales of Xiaoyao pills in physical pharmacies in key cities have increased steadily in recent years, and it is expected that in 2020, it will rise by one position in the TOP20 gynecological Chinese patent medicine products, and will be promoted to third.
Among them, Zhongjing Wanxi Pharmaceutical has the largest market share, close to 60%; followed by Jiuzhitang with more than 15%.
There are many manufacturers of Xiaoyao pills and fierce competition, including more than 150 such as Zhongjing Wanxi Pharmaceutical, Jiuzhitang, Lanzhou Foci Pharmaceutical, and Taiji Group Chongqing Second Chinese Medicine Factory.
Sales of Jiawei Xiaoyao Pills in physical pharmacies in key cities in recent years (unit: ten thousand yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
According to data from Meinenet, the sales of Jiawei Xiaoyao Pills in Chinese urban retail pharmacies have grown steadily in recent years, and are expected to increase by nearly 10% year-on-year in 2020, jumping from 10th to 8th in 2019.
Among them, Beijing Tongrentang Technology Pharmaceutical has the largest market share, with more than 50%; followed by Zhuzhou Qianjin Pharmaceutical with more than 30%.
The manufacturers of Jiawei Xiaoyao Pills include more than 30 companies including Beijing Tongrentang Technology Pharmaceutical, Zhuzhou Qianjin Pharmaceutical, Kunming Traditional Chinese Medicine, Zhongxin Pharmaceutical Lerentang Pharmaceutical, and Tianjin Tasly (Liaoning) Pharmaceutical.
Among them, Beijing Tongrentang Technology Pharmaceutical has the largest market share, with more than 50%; followed by Zhuzhou Qianjin Pharmaceutical with more than 30%.
The manufacturers of Jiawei Xiaoyao Pills include more than 30 companies including Beijing Tongrentang Technology Pharmaceutical, Zhuzhou Qianjin Pharmaceutical, Kunming Traditional Chinese Medicine, Zhongxin Pharmaceutical Lerentang Pharmaceutical, and Tianjin Tasly (Liaoning) Pharmaceutical.
Data source: Mi Neiwang database, company annual report, etc.
